Classes
Publications
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study2018 | First Faculty of Medicine
- Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls2018 | First Faculty of Medicine
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The Inclusion of a Gemcitabine Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine
- Therapeutic algorithm for pancreatic cancer - can we expect improved survival in near future?2016 | First Faculty of Medicine
- Modified FOLFIRINOX in the treatment of pancreatic cancer - efficiency and toxicity2016 | First Faculty of Medicine
- Immunoscore and its predictive value for colorectal cancer2015 | First Faculty of Medicine
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
Loading network view...